To address the potential medicines of tomorrow, a panel of experts will discuss emerging therapies and the potential of developing new medicines and repurposing old medicines on Tuesday Nov. 5, 2019 at CPhI in Frankfurt, Germany.
Emerging therapeutic areas, such as oncology, cardiovascular, autoimmune, pulmonary, and mental health, are becoming more and more important for pharma companies. These conditions often encompass complex and difficult disease processes that can require individualized treatment.
To address the potential medicines of tomorrow, a panel of experts will discuss emerging therapies and the potential of developing new medicines and repurposing old medicines on Tuesday Nov. 5, 2019 at CPhI in Frankfurt, Germany. Some of the topics for consideration will be value added medicines, personalized therapies, the market shift towards niche therapies, and the future of generics.
The panel of experts participating in the discussion will be Aurelio Arias (IQVIA), Subodh Deshmukh (Sandoz), Ken Phelps (Camargo Pharmaceutical Services), Dr. Thomas Solbach (Strategy&), Paul Thorning (Crystec Pharma), and Dr. Andreas Wicki (KSBL).
The Future of Medicine: What are the therapies of tomorrow?Tuesday Nov. 5, 201910:30–11:40CPhI Theatre (61D61)
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.